German drug major Merck KgaA reported Thursday higher net profit in its second quarter with increased sales. The company generated improved sales in Healthcare and Life Science segments, and all regions except Europe. Meanwhile, EBITDA, a key earnings metric, declined. Looking ahead, the company manitained its fiscal 2017 adjusted earnings view, but trimmed sales forecast on exchange rate impacts.
from RTT - Earnings http://ift.tt/2wnJ2jM
via IFTTT
No comments:
Post a Comment